Methods for treating symptoms of dry eye disease
US12053501B2 · kind B2 · utility
0Cited by
9References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 8, 2021 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Apr 28, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to, among other things, compositions and methods for treating an inflammatory condition including, but not limited to, ocular inflammation, dry eye disease, and ocular neuropathic pain. One aspect of the present disclosure relates to a composition comprising (a) chemerin or a fragment or analog thereof and (b) a lipid entity linked to the chemerin or fragment or analog thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.